Global Development Lead

**At Bayer we’re visionaries, driven to solve the world’s toughest challenges and striving for a world where ,Health for all, Hunger for none’ is no longer a dream, but a real possibility. We’re doing it with energy, curiosity and sheer dedication, always learning from unique perspectives of those around us, expanding our thinking, growing our capabilities and redefining ‘impossible’. There are so many reasons to join us. If you’re hungry to build a varied and meaningful career in a community of brilliant and diverse minds to make a real difference, there’s only one choice.**

**Global Development Lead - CPO**

**YOUR TASKS AND RESPONSIBILITIES**:
The Global Development Leader (GDL) will be responsible to ensure the development of a global clinical strategy and the operational conduct of global clinical development activities for all clinical development projects within the worldwide Global Clinical Development Organization for assigned programs in the Oncology portfolio and line management responsibilities of multiple Clinical Development Leaders.

The GDL will also be responsible for the clinical leadership of the Global Development Team(s) (GDTs) ensuring appropriate representation of the programs under their leadership internally and externally. The GDL is a key member of the Integrated Product Team (IPT) and may be considered for the IPT lead or co-lead role.
- Global, strategic clinical oversight of molecules in their programs.
- Responsible to ensure the development of a global clinical strategy and the operational conduct of global clinical development activities for clinical development projects within the worldwide Global Clinical Development Organization that fall within the Strategic Business Unit Oncology.
- This includes development of new molecular entities from Phase II (or earlier proof of concept) through Phase III and registration/launch, and development for marketed products designed to optimize product value e.g. Phase IV studies, development of new indications, or development of new formulations.
- The purpose is to accelerate, streamline and strengthen the global clinical development effort so that investigational drugs may be approved more rapidly and positioned more competitively in the international marketplace (including the U.S.). For drugs already marketed, the purpose is to expand indications and/or support marketing on a global basis. All development activities will be consistent with the strategy set by the brand IPT.
- Working closely with Research and Early Development (RED) Oncology to align on development strategy for early compounds; advocating the ONE Oncology mindset.
- Managing and directing a team of Clinical Development Leaders (CDLs). These direct reports can be located at Global Oncology Hubs, i.e. Berlin, (Germany), Basel (Switzerland), Milan (Italy),or Whippany, Boston (USA), respectively.
- Proactively manage the Bayer R&D portfolio of the respective molecules in the programs, including proactive search, evaluation and execution of licensing opportunities in close interaction with the Global Therapeutic Area Heads in Research and Early Development and the respective BU, and appropriate decision making by the respective internal committees
- Sets project-related objectives and personal development goals with CDLs' and conducts their annual performance evaluation.
- Develop and maintain a motivated and competent staff by assuring that hiring, compensation, development, and advancement are all in line with talents and expectations and by working with key departmental managers across legal entities in planning, development and delivery of a services.
- Close interaction with Early Development and Research to provide critical medical input and guidance for the management of the Bayer portfolio within Oncology.
- Embeds compliance as fundamental business principle in his/her group.

**WHO YOU ARE**:
The incumbent is a highly successful M.D. with extensive professional and academic experience, preferably with board certification in oncology or hematology/oncology.

You have experience in late development phases including leading of one or more agents to a regulatory approval is preferred.
- Current knowledge and experience of drug development in patients
- Knowledge of the whole R&D process and the key drivers for success
- Strong understanding of the elements of drug development programs
- Current knowledge of regulatory review and responses
- Exposure to and understanding of commercial considerations in relation to drug development
- Evidence of ability to lead and manage a team to deliver to time, cost and quality requirements.
- Able to manage diverse activities to deliver milestones according to set budgets. Sets priorities and organizes a team effectively.
- Able to manage and develop both direct reports and matrixed team members, including performance management and change management
- Capable of recognizing when team interventions are required